VERO PHARM s.r.o.

Active
IČO 34119744limited liability company (s.r.o.)Founded 1995Piešťany

Key figures

1 329 966 €+34,4%
Revenue 2025
+13,2%
Average annual growth 2020–2025
0500 k1 m1,5 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 5 448 €.

Low confidence: the amount exceeds the retained earnings from which dividends can be distributed — probably a merger, an opening balance adjustment or an error in the financial statements.

History
2025 ~5 448 €
2024 ~3 219 €
20230 €
20220 €
20210 €

Summary: VERO PHARM s.r.o.

What kind of company is it?

VERO PHARM s.r.o. (IČO 34119744) is a limited liability company (s.r.o.). The company was incorporated in 1995 and has existed for 31 years. Registered office according to the register: Piešťany. Main activity according to the Statistical Office: maloobchod s farmaceutickými výrobkami (SK NACE 4773). Size category by number of employees: 3–4 employees.

Who runs the company and who owns it?

The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 6 640 €.

How is the company doing financially?

Revenue for 2025 was 1 329 966 €, up 34,4 % on the previous year (989 761 €). From 2020 to 2025, revenue grew by an average of 13,2 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 16 341 € (1,2 % of revenue). The company was profitable in 4 of the 6 reported years. Personnel costs for 2025 were 82 043 €. At the end of 2025 the company had total assets of 234 221 € and equity of 28 002 € (equity ratio 12,0 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 18. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)795 495912 170806 238989 7611 329 966
Profit for the reporting year-4 5154473 2199 96316 341
Retained earnings of previous periods-46 306-50 821-50 821-50 821-46 306
Total assets223 250176 302158 804198 155234 221
Total liabilities216 104168 709148 439181 046206 219
Total equity7 1467 59310 36517 10928 002
Calculated dividends0003 2195 448

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Documents in the Register of Financial Statements10

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 4773)
VERO PHARM s.r.o. (IČO 34119744) – revenue 1,3M € | icoprofil.sk